Strategies to Enhance Immunotherapy in Cancer


(MedPage Today) — NATIONAL HARBOR, Md. — As many as a fourth of patients with anti-PD-1-resistant melanoma attained meaningful responses with intralesional injection of a toll-like receptor 9 agonist, according… Source link